umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Crizotinib: latest champion in the cancer wars?
Umeå University, Faculty of Science and Technology, Department of Molecular Biology (Faculty of Science and Technology).
Umeå University, Faculty of Science and Technology, Department of Molecular Biology (Faculty of Science and Technology).
2010 (English)In: New England Journal of Medicine, ISSN 0028-4793, E-ISSN 1533-4406, Vol. 363, no 18, 1760-1762 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2010. Vol. 363, no 18, 1760-1762 p.
Keyword [en]
anaplastic lymphoma kinase; lung-cancer; alk; identification; inhibitors; gene; domain
National Category
Family Medicine
Identifiers
URN: urn:nbn:se:umu:diva-43278DOI: 10.1056/NEJMe1010404ISI: 000283546400013PubMedID: 20979477OAI: oai:DiVA.org:umu-43278DiVA: diva2:412719
Available from: 2011-04-26 Created: 2011-04-26 Last updated: 2017-12-11Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Hallberg, BengtPalmer, Ruth H
By organisation
Department of Molecular Biology (Faculty of Science and Technology)
In the same journal
New England Journal of Medicine
Family Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 85 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf